Physician profile
Roberto Ruiz
NPI 1770578148
$25,422.76
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $1,925 · 2021: $386 · 2022: $36.65 · 2023: $34.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $10,738.13 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $8,293.86 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $2,790.66 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $651.83 | 2019 | |
| Allergan, INC. | $628.64 | 2019-2022 | |
| Novo Nordisk INC | $342.53 | 2019-2020 | |
| Abbott Laboratories | $325.51 | 2019-2020 | |
| Lilly USA, LLC | $271.02 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.79 | 2019-2020 | |
| Genentech USA, INC. | $148.69 | 2019 | |
| Amarin Pharma, INC. | $125.11 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $117.69 | 2020 | |
| Janssen Pharmaceuticals, INC | $110.36 | 2019-2020 | |
| Medtronic Minimed, INC. | $94.03 | 2019 | |
| Corcept Therapeutics | $75.02 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $72.21 | 2020 | |
| Becton, Dickinson and Company | $60.51 | 2019 | |
| Avion Pharmaceuticals | $34.09 | 2023 | Dhivy |
| Valeritas, INC. | $33.53 | 2019 | |
| Vivus LLC | $31.35 | 2019 | |
| Amgen INC. | $29.95 | 2020 | |
| Janssen Scientific Affairs, LLC | $29.75 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.54 | 2019-2020 | |
| Boston Scientific Corporation | $25.62 | 2019-2021 | |
| Antares Pharma, INC. | $24.66 | 2019 | |
| Medtronic Vascular, INC. | $19.44 | 2020 | |
| Shire North American Group INC | $18.49 | 2019 | |
| Pfizer INC. | $15.23 | 2019 | |
| Companion Medical, INC. | $13.49 | 2020 | |
| Stryker Corporation | $12.19 | 2020 | |
| Aytu Biopharma, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.